(10)Commission Directive 2007/76/ECnote included fludioxonil and clomazone in Annex I to Directive 91/414/EEC as active substances until 31 October 2018 and they were subsequently included in Part A of the Annex to Implementing Regulation (EU) No 540/2011. The approvals of fludioxonil and clomazone were extended seven times each, most recently by Commission Implementing Regulation (EU) 2025/787note, both until 30 September 2026.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.